Skip to content

Humidification of Noninvasively Ventilated Patients

Humidification of patients on noninvasive bi-level ventilation (NIV): Effects on levels of patient agitation and compliance

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000466640
Enrollment
15
Registered
2005-09-23
Start date
2005-07-04
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Patients prescribed to receive noninvasive ventilation will be randomized to receive either: Humidification delivered at 31°C and 32 mg H2O/L or No humidification added They will receive this therapy for as long as noninvasive ventilation is given to them. Study data will be collected for a maximum of 24 hours.

Sponsors

Fisher & Paykel Healthcare
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Receiving bi-level ventilation for more than 60 minutes.

Exclusion criteria

Are or have been weaned from mechanical ventilation.Suffer dementia.Have a tracheostomy.Have had recent oral, esophogeal or gastric surgery.Have a contraindication to NIV.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026